| Megan Johnston, LCSW | |
|
701 W 41st Ave Ste 104, Anchorage, AK 99503-6604 | |
| (907) 782-4553 | |
| (907) 563-0131 |
| Full Name | Megan Johnston |
|---|---|
| Gender | Female |
| Speciality | Social Worker - Clinical |
| Location | 701 W 41st Ave Ste 104, Anchorage, Alaska |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1396317160 | NPI | - | NPPES |
| 2135655 | Medicaid | AK |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 1041C0700X | Social Worker - Clinical | CSWS808 (Alaska) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Megan Johnston, LCSW 22909 Eagle River Rd, Eagle River, AK 99577-9525 Ph: (907) 223-7155 | Megan Johnston, LCSW 701 W 41st Ave Ste 104, Anchorage, AK 99503-6604 Ph: (907) 782-4553 |
News Archive
CombinatoRx, Incorporated and Neuromed Pharmaceuticals Inc., a privately-held biopharmaceutical company, today announced that the U.S. Food and Drug Administration (FDA) has issued Neuromed a letter extending its review of the New Drug Application (NDA) for the product candidate Exalgo™ (hydromorphone HCl) extended-release tablets by three months.
Two of Almac's main research projects have been selected for presentation at the 2011 ASCO meeting. Both of these studies are based on Almac's approach of profiling large clinical datasets and analysing the data for molecular subgroups that can aid in improved diagnosis of cancer by identifying molecular subtypes and by identifying molecular subgroups which are of clinical and therapeutic relevance.
According to researchers patients given a mix of modern blood pressure drugs are one-third less likely to develop diabetes than those on older pills.
In a recent article publicly available at medRxiv, researchers from Stanford have presented a single-cell atlas of the peripheral immune response to coronavirus disease (COVID-19), highlighting pertinent immunological features associated with the severe forms of the disease.
A Food and Drug Administration (FDA) panel yesterday recommended the approval of Orexigen Therapeutics' weight loss drug Contrave. This is the first time a weight loss drug has received the nod. The vote went 13 to 7 for Contrave's approval and 11 to 8, with an abstention that additional studies be conducted on heart risks. Although experts agree to risks they believe the benefits outweigh the risks. Although the FDA is not compelled to go with the panel's recommendation, it more often than not does. The FDA will deliver its verdict by Jan. 31 2011.
› Verified 3 days ago
Mrs. April Shinora Mclamb, LCSW Clinical Social Worker Medicare: Medicare Enrolled Practice Location: 600 W 41st Ave Ste 203b, Anchorage, AK 99503 Phone: 907-412-3487 | |
Shelley Lenee Reppel, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 3820 Lake Otis Pkwy, Suite 100, Anchorage, AK 99508 Phone: 907-569-6906 Fax: 907-569-6908 | |
Ms. Constance Matthews Greco, L.C.S.W. Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 10250 Jamestown Dr Apt 15, Anchorage, AK 99507 Phone: 907-522-8170 | |
Anna M. Stafford, LCSW Clinical Social Worker Medicare: Medicare Enrolled Practice Location: 4130 San Ernesto Ave, Anchorage, AK 99508 Phone: 907-729-5070 | |
Joshua Aaron Goldstein, Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 3000 C St Ste 202, Anchorage, AK 99503 Phone: 907-729-8558 | |
Megan Hultquist, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 3300 Providence Dr, Suite B314, Anchorage, AK 99508 Phone: 907-212-3420 Fax: 907-212-3429 | |
Ulani Vinesa Luafulu, Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 2910 W 32nd Ave Apt 3, Anchorage, AK 99517 Phone: 907-726-3585 |